SV Investment Corporation
Research SV Investment Corporation (289080.KQ) on Bullrun: market cap KRW 146.74B, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker289080.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorFinancial Services
- IndustryAsset Management
- CurrencyKRW
- Market capKRW 146.74B
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueKRW 9.15B
- Net incomeKRW 776.14M
- Free cash flowKRW 1.45B
- Gross margin76.4%
Valuation Snapshot
latest market cap is KRW 146.74B; dividend yield is 0.8%.
Peer valuation comparison
Latest dividend yield is 0.82% versus a Financial Services sector median of 3.54% (76.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 146.74B | n/a | 0.8% | 20 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 20 KRW, yield 0.8%.
About SV Investment Corporation
SV Investment Corporation is a private equity and venture capital firm. It considers investments in companies at early, mid, and late venture stages and private investments in public equities. The firm specializes in growth capital and buyouts. It also considers investments in healthcare, biotechnology, biopharmaceutical, cultural entertainment, technology, media, telecommunications, information technology, culture-information communication technology convergence, and consumer sectors.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is SV Investment Corporation's market cap?
SV Investment Corporation's market capitalization is KRW 146.74B.
Does SV Investment Corporation pay a dividend?
SV Investment Corporation has a dividend yield of 0.8%.
What does SV Investment Corporation do?
SV Investment Corporation is a private equity and venture capital firm. It considers investments in companies at early, mid, and late venture stages and private investments in public equities. The firm specializes in growth capital and buyouts. It also considers investments in healthcare, biotechnology, biopharmaceutical, cultural entertainment, technology, media, telecommunications, information technology, culture-information communication technology convergence, and consumer sectors.